Washington—Specialty drug spending growth might be slowing down—at least a bit, according to Doug Long, who spoke at the 2016 National Association of Specialty Pharmacy’s annual meeting.
In 2015, many experts forecast double-digit growth in spending on the drug class. But based on current market trends, he expected single-digit rather than double-digit gains, warned Mr. Long, the vice president of industry relations at QuintilesIMS.
“A lot of our advocators were thinking